WEST PHARMACEUTICAL SERVICES INC 4
4 · WEST PHARMACEUTICAL SERVICES INC · Filed Jun 2, 2016
Insider Transaction Report
Form 4
Malone Daniel
Vice President & Controller
Transactions
- Exercise/Conversion
Common Stock
2016-06-02$22.48/sh+3,950$88,816→ 30,665.502 total - Exercise/Conversion
Stock Option (Right to Buy)
2016-06-02$22.48/sh−3,950$88,816→ 0 totalExercise: $22.48From: 2008-02-27Exp: 2017-02-27→ Common Stock (3,950 underlying) - Sale
Common Stock
2016-06-02$74.95/sh−3,950$296,057→ 26,715.502 total
Footnotes (2)
- [F1]The price reported in Column 4 is an average price. These shares were sold in multiple transactions at prices ranging from $74.76 to $75.08, inclusive. The reporting person undertakes to provide to West PharmaceuticalServices, Inc., any security holder of West Pharmaceutical Services, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate pricewithin the range in this footnote.
- [F2]Reflects additional shares purchased through dividend reinvestments based on most recent plan statement.